Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells

Can neutrophil/lymphocyte ratio be a novel biomarker of inflammation in children with asthma?

(2016) Hikmet Tekin Nacaroglu et al.   European Journal of Inflammation

17β-estradiol modulates the viability, phenotype, endocytosis, and inflammatory cytokine expression of RAW264.7 macrophages

(2016) Linsong Yang et al.   European Journal of Inflammation

Levels of circulating soluble receptor activator of NF-κB and interleukins-1 predicting outcome of locally advanced basal cell carcinoma

(2016) Quan Lin et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Analysis of changes in expression of IL-4/IL-13/STAT6 pathway and correlation with the selected clinical parameters in patients with atopic asthma

(2016) Adam Antczak et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Cyclic nucleotide phosphodiesterase isoforms in human basophils and mast cells

(2016) Nahid Eskandari et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies

(2016) Clementina Canessa et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Beneficial effects of IL-37 after spinal cord injury in mice

(2016) Marina Coll-Miró et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation

(2016) Giulio Cavalli et al.   RHEUMATOLOGY

IL-4 and IL-13 signaling in allergic airway disease

(2015) Naina Gour et al.   CYTOKINE

Mast Cell Serotonin Immunoregulatory Effects Impacting on Neuronal Function: Implications for Neurodegenerative and Psychiatric Disorders

(2015) P. Conti et al.   NEUROTOXICITY RESEARCH

Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8

(2015) Suzhao Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Allergic airway inflammation: unravelling the relationship between IL-37, IL-18Rα and Tir8/SIGIRR

(2015) Lars Lunding et al.   Expert Review of Respiratory Medicine

Spectrum of mast cell activation disorders

(2014) Anastasia I Petra et al.   Expert Review of Clinical Immunology

Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells

(2014) Yuchun Luo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-37 Inhibits Inflammasome Activation and Disease Severity in Murine Aspergillosis

(2014) Silvia Moretti et al.   PLoS Pathogens

The Interleukin-1 Family: Back to the Future

(2013) Cecilia Garlanda et al.   IMMUNITY

Do mast cells link obesity and asthma?

(2012) N. Sismanopoulos et al.   ALLERGY

Vascular Endothelial Growth Factor as a Key Inducer of Angiogenesis in the Asthmatic Airways

(2012) Norbert Meyer et al.   CURRENT ALLERGY AND ASTHMA REPORTS

A clinical perspective of IL-1β as the gatekeeper of inflammation

(2011) Charles A. Dinarello   EUROPEAN JOURNAL OF IMMUNOLOGY

IL-37 is a fundamental inhibitor of innate immunity

(2010) Marcel F Nold et al.   NATURE IMMUNOLOGY